Please use this identifier to cite or link to this item:
|Title:||De novo activating epidermal growth factor mutations (EGFR) in small-cell lung cancer.|
|Authors:||Thai, Alesha;Chia, Puey L;Russell, Prudence A;Do, Hongdo;Dobrovic, Alexander;Mitchell, Paul L R;John, Thomas|
|Affiliation:||Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia|
Department of Anatomical Pathology, St Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
|Citation:||Internal Medicine Journal 2017; 47(9): 1071-1074|
|Abstract:||In Australia, mutations in epidermal growth factor mutations (EGFR) occur in 15% of patients diagnosed with non-small-cell lung cancer and are found with higher frequency in female, non-smokers of Asian ethnicity. Activating mutations in the EGFR gene are rarely described in SCLC. We present two cases of de novo EGFR mutations in patients with SCLC detected in tissue and in plasma cell free DNA, both of whom were of Asian ethnicity and never-smokers. These two cases add to the growing body of evidence suggesting that screening for EGFR mutations in SCLC should be considered in patients with specific clinical features.|
cell free DNA
small-cell lung cancer
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.